Synchronous primary atypical pulmonary carcinoid and cecal adenocarcinoma: a case report
DOI:
https://doi.org/10.2478/AMB-2026-0074Keywords:
atypical pulmonary carcinoid, synchronous malignancy, cecal adenocarcinoma, surgical treatment, double primary malignancyAbstract
Abstract. Pulmonary carcinoid tumors are a rare subgroup of neuroendocrine lung neoplasms, accounting for approximately 1-2% of all primary lung cancers. The occurrence of synchronous primary malignancies involving pulmonary carcinoid and colorectal adenocarcinoma is exceptionally uncommon. We report a 78-year-old woman initially diagnosed with an endobronchial atypical carcinoid tumor of the left lower lobe. After initial refusal of surgical treatment by the patient and following endoscopic management, a left lower lobectomy with systematic lymphadenectomy was performed. Histopathology confirmed a G2 atypical carcinoid (pT1cN0R0, stage I). One month later, the patient developed symptomatic anemia and abdominal pain. Colonoscopy revealed a stenosing adenocarcinoma of the cecum. A right hemicolectomy with en bloc resection of infiltrated adjacent structures was performed. Final staging demonstrated moderately differentiated adenocarcinoma (pT3N0R0, stage IIA). The postoperative course after both procedures was uneventful, and the patient was referred for adjuvant oncologic evaluation. Synchronous primary atypical pulmonary carcinoid and colorectal adenocarcinoma is rare. This case underscores the importance of distinguishing metastatic disease from synchronous independent primaries in elderly patients with newly diagnosed malignancies and highlights the role of multidisciplinary staged surgical management in achieving favorable outcomes.
References
Granberg D, Juhlin CC, Falhammar H, et al. Lung carcinoids: a comprehensive review for clinicians. Cancers, 2023, 15(22):5440. doi:10.3390/cancers15225440
Yang Z, Wang Z, Duan Y, et al. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung. Thorac Cancer, 2016, 7(6):633-638. doi:10.1111/1759-7714.12377
Georgakopoulou VE, Zygouris E, Nikokiris C, et al. Predictive indicators of survival in patients with surgically resected lung carcinoid tumors at a Greek medical center. Cureus, 2020, 12(9):e10300. doi:10.7759/cureus.10300
Nistor CE. Surgical approach of lung carcinoid tumors. Acta Endocrinol (Buchar), 2022, 18(2):258-261. doi:10.4183/AEB.2022.258
World Cancer Research Fund. Worldwide cancer data. World Cancer Research Fund website. Available from: https://www.wcrf.org/preventing-cancer/cancer-statistics/worldwide-cancer-data. Accessed on 25 February 2026.
Salibasic M, Pusina S, Bicakcic E, et al. Colorectal cancer surgical treatment, our experience. Med Arch, 2019, 73(6):412414. doi:10.5455/medarh.2019.73.412-414
Tsai HJ, Wu CC, Tsai CR, et al. Second cancers in patients with neuroendocrine tumors. PLoS One, 2013, 8(12):e86414. doi:10.1371/journal.pone.0086414
Kamp K, Damhuis RA, Feelders RA, et al. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas. Endocr Relat Cancer, 2012, 19(1):95-99. doi:10.1530/ERC-11-0315
Aleksiev V, Yavorov B, Markov D. Comprehensive clinicodemographic analysis of malignant pleural effusions in the Bulgarian population: insights from an observational case-control study. Acta Med Bulg, 2025, 52(2):44-51. doi:10.2478/AMB-2025-0043
Ivanova S, Cherneva R, Krasteva R, et al. Minimally invasive lung adenocarcinoma, Mycobacterium avium intracellulare and Langerhans histiocytosis. Acta Med Bulg, 2025, 52(3):6871. doi:10.2478/AMB-2025-0063
Reuling EMBP, Dickhoff C, Plaisier PW, et al. Endobronchial treatment for bronchial carcinoid: patient selection and predictors of outcome. Respiration, 2018, 95(4):220-227. doi:10.1159/000484984
Russell B, White BE, Rous B, et al. Second primary malignancies in patients with a neuroendocrine neoplasm in England. Neuroendocrinology. 2023;113(8):811-821. doi:10.1159/000530238.
Sachithanandan N, Harle RA, Burgess JR. Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer. 2005;103(3):509-15. doi: 10.1002/cncr.20825.
Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 2000 Dec;75(4):310-6. doi: 10.1002/1096-9098 (200012)75:4<306::aid-jso14>3.0.co;2-3.
Clift AK, Drymousis P, Al-Nahhas A, et al. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours. Neuroendocrinology. 2015;102(1-2):26-32. doi: 10.1159/000381716.
Alghanmi HA. Successful treatment of synchronous double lung primary malignancies and colon cancer. Cureus. 2022;14(2):e22552. doi:10.7759/cureus.22552.
Moutardier V, Turrini O, Lelong B, et al. Consecutive multiple organ resections for locally advanced colon cancer. Chir Ital, 2020, 33:160-163. doi:10.23736/S0394-9508.19.04981-7
Angelov K, Nachev N, Yordanov E, et al. A narrative review study summarizing and interpreting the existing literature on the diagnosis and treatment of small bowel tumors. Acta Med Bulg, 2026, 53(Suppl 1):216-223. doi:10.2478/AMB-2026-0033
Angelov K, Nachev N, Yordanov E, et al. Diagnostic and therapeutic approaches in the treatment of gastric cancer – a scoping review. Acta Med Bulg, 2026, 53(Suppl 1):232-238. doi:10.2478/AMB-2026-0035
Janež J, Škapin AD. Comparison of a five-year survival and cancer recurrence between laparoscopically assisted and open colonic resections due to adenocarcinoma: a single-centre experience. Medicina (Kaunas), 2020, 56(2):93. doi:10.3390/medicina56020093
Downloads
Published
Issue
Section
License
Copyright (c) 2026 G. Gergov, M. Alexieva, E. Mekov, N. Yanev, R. Petkov, G. Yankov (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.


Journal Acta Medica Bulgarica